Perioperative management of diabetes mellitus: How should we act on the limited evidence?
Byron J. Hoogwerf, MD
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic Foundation, Cleveland, OH
Correspondence: Byron J. Hoogwerf, MD, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic Foundation, 9500 Euclid Avenue, A53, Cleveland, OH 44195; firstname.lastname@example.org
Dr. Hoogwerf reported that he has received grants from the Amylin and Lilly corporations; serves as a consultant to the Takeda and Pfizer corporations; and serves on the speakers’ bureaus of the Merck, Schering-Plough, Pfizer, Lilly, Amylin, AstraZeneca, and Takeda corporations.